PPARG and colitis: In 2001, Desreumaux et al. investigated the role of the RXR-PPAR-γ heterodimer in intestinal inflammation by exploring the effects of both PPAR-γ and RXR agonists in an animal model in which colitis was induced by intra-rectal administration of TNBS.